Most kidney studies on CCL2/CCR2 have reported that kidney function can be recovered by treatment with CCR2 inhibitor in type 2 diabetes through reducing albuminuria and changing glomerular structure et al [31–33]. The gene discussed is CCR2; the disease is type 2 diabetes mellitus.